GR930100197A - Νέες φαρμακευτικές συν?έσεις που περιέχουν σιμε?εικόνη. - Google Patents

Νέες φαρμακευτικές συν?έσεις που περιέχουν σιμε?εικόνη.

Info

Publication number
GR930100197A
GR930100197A GR930100197A GR930100197A GR930100197A GR 930100197 A GR930100197 A GR 930100197A GR 930100197 A GR930100197 A GR 930100197A GR 930100197 A GR930100197 A GR 930100197A GR 930100197 A GR930100197 A GR 930100197A
Authority
GR
Greece
Prior art keywords
simethicone
novel
pharmaceutical compositions
containing pharmaceutical
treatment
Prior art date
Application number
GR930100197A
Other languages
English (en)
Other versions
GR1002332B (el
Inventor
Stevens A Charles
Michael R Hoy
Edward J Roche
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26715151&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR930100197(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of GR930100197A publication Critical patent/GR930100197A/el
Publication of GR1002332B publication Critical patent/GR1002332B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μια στερεά από του στόματος μορφή δοσιμετρήσεως δια την θεραπευτική αγωγή γαστροεντερικών διαταραχών που περιέχει μίας θεραπευτικώς αποτελεσματική ποσότητα μιάς φαρμακευτικής ουσίας καταλλήλου δια την θεραπευτική αγωγή γαστρικών διαταραχών, η οποία εκλέγεται από την ομάδα που αποτελείται από κιμετιδίνη, ρανιτιδίνη, φαμοτιδίνη, διφαινοξυλάκη, λοπεραμίδη, λοπεραμιδο-Ν-οξείδιο, φαρμακευτικώς παραδεκτά άλατα αυτών και συνδυασμούς αυτών και μία θεραπευτικώς αποτελεσματική ποσότητα σιμεθικόνης όπου η φαρμακευτική ουσία και η σιμεθικόνη διαχωρίζονται από ένα διάφραγμα το οποίο ουσιαστικά είναι αδιαπέραστο από τη σιμεθικόνη.ω
GR930100197A 1992-05-21 1993-05-17 Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη. GR1002332B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88720792A 1992-05-21 1992-05-21
US3839793A 1993-03-29 1993-03-29

Publications (2)

Publication Number Publication Date
GR930100197A true GR930100197A (el) 1994-01-31
GR1002332B GR1002332B (el) 1996-05-16

Family

ID=26715151

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930100197A GR1002332B (el) 1992-05-21 1993-05-17 Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.

Country Status (7)

Country Link
US (4) US5679376A (el)
EP (1) EP0571217B1 (el)
BR (1) BR1100507A (el)
CA (1) CA2096575C (el)
DE (1) DE69315257T2 (el)
ES (1) ES2112387T3 (el)
GR (1) GR1002332B (el)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004128A1 (de) * 1994-08-03 1996-02-15 Voss Gunter M Verfahren zur herstellung von manteltabletten
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US6537525B1 (en) * 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6800329B2 (en) * 1999-02-12 2004-10-05 Lts Lohmann Therapie-Systeme Ag Method for producing film-type dosage
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6100245A (en) * 1999-09-07 2000-08-08 Mcneil-Ppc, Inc. Use of simethicone to treat ulcerative colitis
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
MXPA02004413A (es) * 1999-11-02 2002-09-02 Depomed Inc Induccion farmacologica del modo de alimentacion, para la administracion aumentada de drogas al estomago.
ES2247163T3 (es) * 2000-06-23 2006-03-01 Bioprojet Formulacion en polvo seca que comprende racedotril.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6669271B2 (en) * 2001-06-22 2003-12-30 East Manufacturing Corporation Smooth side body structure and method
MXPA04002977A (es) 2001-09-28 2005-06-20 Johnson & Johnson Forma de dosificacion que contiene una composicion de confiteria.
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
US20050180920A1 (en) * 2003-01-29 2005-08-18 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7378081B2 (en) * 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7096533B2 (en) * 2004-06-12 2006-08-29 Kruegar International, Inc. Locking roller for an article of furniture
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
WO2007102726A1 (es) * 2006-03-09 2007-09-13 World-Trade Import-Export, Wtie, Ag. Combinacion sinergica de inhibidores de receptores h2, silicon inerte y un complejo aluminato de hidroximagnesio
US7976872B2 (en) * 2006-07-24 2011-07-12 L. Perrigo Company Method for distributing a pharmaceutically active compound in an excipient
US7754041B2 (en) * 2006-07-31 2010-07-13 3M Innovative Properties Company Pleated filter with bimodal monolayer monocomponent media
US7662373B2 (en) * 2006-09-18 2010-02-16 Thompson Ronald J Method and composition of a medicament to decrease the adverse events of Olistat, an oral lipase inhibitor
WO2008056200A1 (en) * 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of simethicone
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
JP2012531409A (ja) 2009-06-25 2012-12-10 アストラゼネカ・アクチエボラーグ Ｎｓａｉｄ関連潰瘍を発症するリスクがある患者の処置方法
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
WO2016200345A1 (en) 2015-06-12 2016-12-15 Santa Farma İlaç Sanayi̇ A. Ş. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics.
CN108712900A (zh) 2015-12-19 2018-10-26 第时间美国泛型药物有限公司 软咀嚼片剂药物制剂
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
CN111132667A (zh) 2017-09-29 2020-05-08 强生消费者公司 固体西甲硅油颗粒及其剂型
CA3091678A1 (en) * 2018-02-26 2019-08-29 R.P. Scherer Technologies, Llc Pharmaceutical dosage form for an emulsion of simethicone and loperamide
GR1009632B (el) * 2018-07-09 2019-10-25 Ιουλια Κλεωνος Τσετη Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος
KR20240095472A (ko) * 2021-11-16 2024-06-25 존슨 앤드 존슨 컨수머 인코포레이티드 시메티콘을 함유하는 맞춤화 가능한 투여 형태
WO2023187225A1 (en) * 2022-04-01 2023-10-05 Amplicon Ab Alkaline intraoral products

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
NL7504704A (nl) * 1974-05-16 1975-11-18 Hoffmann La Roche Geneesmiddel.
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
CA1139221A (en) * 1978-10-10 1983-01-11 Vijay B. Surpuriya Antacid compositions
US4198390A (en) * 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
US4316888A (en) * 1980-04-15 1982-02-23 Nelson Research & Development Co. Method and composition of reducing pain
US4428927A (en) * 1981-05-11 1984-01-31 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4857324A (en) * 1985-10-08 1989-08-15 American Home Products Corporation (Del.) Exogenously acidified antacid compositions having cytoprotective properties
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
ATE73328T1 (de) * 1987-05-08 1992-03-15 Smith Kline French Lab Pharmazeutische zusammensetzungen.
US5275819A (en) * 1989-02-06 1994-01-04 Amer Particle Technologies Inc. Drug loaded pollen grains with an outer coating for pulsed delivery
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
IN171919B (el) * 1989-11-01 1993-02-06 Mcneil Ppc Inc
US5204118A (en) * 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5116847A (en) * 1991-01-25 1992-05-26 The Procter & Gamble Company Use of loperamide and related compounds for treatment of respiratory disease symptoms
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
US5447918A (en) * 1992-07-27 1995-09-05 Mccullough; Ricky W. Gastrointestinal anti-irritant composition comprising sucralfate and methods of use
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids

Also Published As

Publication number Publication date
EP0571217A3 (en) 1994-06-01
US5980944A (en) 1999-11-09
DE69315257D1 (de) 1998-01-02
DE69315257T2 (de) 1998-05-14
US5679376A (en) 1997-10-21
US5716641A (en) 1998-02-10
ES2112387T3 (es) 1998-04-01
CA2096575A1 (en) 1993-11-22
BR1100507A (pt) 2002-04-02
EP0571217B1 (en) 1997-11-19
GR1002332B (el) 1996-05-16
CA2096575C (en) 2003-05-13
US5599577A (en) 1997-02-04
EP0571217A2 (en) 1993-11-24

Similar Documents

Publication Publication Date Title
GR930100197A (el) Νέες φαρμακευτικές συν?έσεις που περιέχουν σιμε?εικόνη.
GR930100475A (el) Φαρμακευτική σύν?εση που περιέχει για γουανιδινο?ειαζολική ένωση και αντιόξινα.
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
RU93058555A (ru) Производные хинуклидина, способ их получения, фармацевтическая композиция, способ лечения или профилактики
SE8804629D0 (sv) New therapeutically active compounds
ATE71293T1 (de) Arzneiformulierung.
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
ATE268174T1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
DK157482A (da) Galenisk praeparat indeholdende gallopamil eller verapamil og fremgangsmaade til fremstilling heraf
FR2680172B1 (fr) Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
ES2059816T3 (es) Sustancias activas fisiologicamente, un procedimiento para la preparacion y composiciones farmaceuticas de las mismas.
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
OA07029A (fr) Le chlorure de gallium, nouveau médicament anti-cancéreux.
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
KR890004705A (ko) 항바이러스성 제제
ES485168A0 (es) Un procedimiento para la preparacion de una composicion far-maceutica util para el tratamiento de la hipercolesteremia.
ES2034484T3 (es) El uso de oxidos de tiadiazol para la preparacion de una composicion farmaceutica para el tratamiento de desordenes de motilidad gastrointestinal.
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
ATE270T1 (de) Neue n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ole und ihre salze; verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.
KR890007737A (ko) 진토작용을 하는 약제
RU94022015A (ru) Композиция, повышающая проникновение через кожу и улучшающая локальное применение лекарств
KR930019626A (ko) 신규의 아세트아미드 유도체 및 그 용도
ATE4713T1 (de) 2-oxo-benzothiazolin-, benzoxazolin- oder indolin-derivate, deren herstellung und derartige verbindungen enthaltende pharmazeutische zusammensetzungen.
RU92016559A (ru) Производные диалкокси-пиридинилбензимидазола, фармацевтическая композиция, способ ингибирования или лечения, способ их получения, применение и промежуточные соединения

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees